A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukaemia.

David Valcárcel, Pau Montesinos, Isabel Sánchez-Ortega, Salut Brunet, Jordi Esteve, David Martínez-Cuadrón, José M. Ribera, Mar Tormo, Javier Bueno, Rafael Duarte, Andrés Llorente, Juan Pio Torres, Ramón Guardia, Miguel A. Sanz, and Jorge Sierra, on behalf of the CETLAM

Research output: Contribution to journalArticleResearch

Original languageEnglish
Pages (from-to)640-648
JournalCancer
Volume17
Issue number5
Publication statusPublished - 1 Jan 2012

Cite this